Download presentation
Presentation is loading. Please wait.
Published byOswin Lynch Modified over 6 years ago
1
Copyright © 2001 American Medical Association. All rights reserved.
From: Increased Plasma Methylmalonic Acid Level Does Not Predict Clinical Manifestations of Vitamin B12 Deficiency Arch Intern Med. 2001;161(12): doi: /archinte Figure Legend: Study population: individuals with an increased plasma methylmalonic acid (P-MMA) concentration (>0.28 µmol/L) between January 1, 1995, and December 31, 1997. Date of download: 10/22/2017 Copyright © 2001 American Medical Association. All rights reserved.
2
Copyright © 2001 American Medical Association. All rights reserved.
From: Increased Plasma Methylmalonic Acid Level Does Not Predict Clinical Manifestations of Vitamin B12 Deficiency Arch Intern Med. 2001;161(12): doi: /archinte Figure Legend: Association between prestudy and follow-up plasma methylmalonic acid (P-MMA) levels in 432 individuals with a prestudy P-MMA level greater than 0.28 µmol/L who were not treated with cyanocobalamin before measurement of P-MMA levels 1.0 to 3.9 years later. Date of download: 10/22/2017 Copyright © 2001 American Medical Association. All rights reserved.
3
Copyright © 2001 American Medical Association. All rights reserved.
From: Increased Plasma Methylmalonic Acid Level Does Not Predict Clinical Manifestations of Vitamin B12 Deficiency Arch Intern Med. 2001;161(12): doi: /archinte Figure Legend: Associations between plasma methylmalonic acid (P-MMA) (A) and plasma total homocysteine (P-tHcy) (B) levels and plasma creatinine level in 432 individuals not treated with cyanocobalamin. Date of download: 10/22/2017 Copyright © 2001 American Medical Association. All rights reserved.
4
Copyright © 2001 American Medical Association. All rights reserved.
From: Increased Plasma Methylmalonic Acid Level Does Not Predict Clinical Manifestations of Vitamin B12 Deficiency Arch Intern Med. 2001;161(12): doi: /archinte Figure Legend: Associations between plasma methylmalonic acid (P-MMA) levels and hematologic markers (A, blood hemoglobin level; B, erythrocyte mean cell volume) in 432 individuals not treated with cyanocobalamin. Date of download: 10/22/2017 Copyright © 2001 American Medical Association. All rights reserved.
5
Copyright © 2001 American Medical Association. All rights reserved.
From: Increased Plasma Methylmalonic Acid Level Does Not Predict Clinical Manifestations of Vitamin B12 Deficiency Arch Intern Med. 2001;161(12): doi: /archinte Figure Legend: Neurological symptoms by level of plasma methylmalonic acid (P-MMA) and age group in 403 individuals not treated with cyanocobalamin. Date of download: 10/22/2017 Copyright © 2001 American Medical Association. All rights reserved.
6
Copyright © 2001 American Medical Association. All rights reserved.
From: Increased Plasma Methylmalonic Acid Level Does Not Predict Clinical Manifestations of Vitamin B12 Deficiency Arch Intern Med. 2001;161(12): doi: /archinte Figure Legend: Neurological Disability Scores (NDS) by level of plasma methylmalonic acid (P-MMA) and age group in 403 individuals not treated with cyanocobalamin. Date of download: 10/22/2017 Copyright © 2001 American Medical Association. All rights reserved.
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.